117 related articles for article (PubMed ID: 23743668)
21. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
[TBL] [Abstract][Full Text] [Related]
22. Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
Tada H; Tsuchiya N; Satoh S; Kagaya H; Li Z; Sato K; Miura M; Suzuki T; Kato T; Habuchi T
Transplant Proc; 2005 May; 37(4):1730-2. PubMed ID: 15919447
[TBL] [Abstract][Full Text] [Related]
23. Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus.
Maguire O; Tornatore KM; O'Loughlin KL; Venuto RC; Minderman H
Cytometry A; 2013 Dec; 83(12):1096-104. PubMed ID: 24136923
[TBL] [Abstract][Full Text] [Related]
24. The Impact of ABCB1 SNPs on Tacrolimus Pharmacokinetics in Liver or Kidney Transplant Recipients: A Meta-analysis.
Li Z; Wang X; Li D; Cheng S; Dong Y; Yang H; Li X
Curr Pharm Des; 2023; 29(29):2323-2335. PubMed ID: 37817654
[TBL] [Abstract][Full Text] [Related]
25. Effect of ABCB1 3435C>T Genetic Polymorphism on Pharmacokinetic Variables of Tacrolimus in Adult Renal Transplant Recipients: A Systematic Review and Meta-analysis.
Peng W; Lin Y; Zhang H; Meng K
Clin Ther; 2020 Oct; 42(10):2049-2065. PubMed ID: 32888708
[TBL] [Abstract][Full Text] [Related]
26. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
[TBL] [Abstract][Full Text] [Related]
27. Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients.
Crettol S; Venetz JP; Fontana M; Aubert JD; Ansermot N; Fathi M; Pascual M; Eap CB
Pharmacogenet Genomics; 2008 Apr; 18(4):307-15. PubMed ID: 18334915
[TBL] [Abstract][Full Text] [Related]
28. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M
J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250
[TBL] [Abstract][Full Text] [Related]
29. ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitis.
Herrlinger KR; Koc H; Winter S; Teml A; Stange EF; Fellermann K; Fritz P; Schwab M; Schaeffeler E
Clin Pharmacol Ther; 2011 Mar; 89(3):422-8. PubMed ID: 21289623
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry.
Vafadari R; Hesselink DA; Cadogan MM; Weimar W; Baan CC
Transplantation; 2012 Jun; 93(12):1245-51. PubMed ID: 22643331
[TBL] [Abstract][Full Text] [Related]
31. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation.
Chakkera HA; Chang YH; Bodner JK; Behmen S; Heilman RL; Reddy KS; Mulligan DC; Moss AA; Khamash H; Katariya N; Hewitt WR; Pitta TL; Frassetto LA
Transplant Proc; 2013; 45(1):137-41. PubMed ID: 23375287
[TBL] [Abstract][Full Text] [Related]
32. MDR1 genotype-dependent regulation of the aldosterone system in humans.
Zolk O; Jacobi J; Pahl A; Fromm MF; Schmieder RE
Pharmacogenet Genomics; 2007 Feb; 17(2):137-44. PubMed ID: 17301693
[TBL] [Abstract][Full Text] [Related]
33. Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Transplant Patients.
Sy SK; Singh RP; Shilbayeh S; Zmeili R; Conrado D; Derendorf H
Clin Pharmacol Drug Dev; 2013 Jan; 2(1):67-78. PubMed ID: 27121561
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.
Ahmed M; Venkataraman R; Logar AJ; Rao AS; Bartley GP; Robert K; Dodson FS; Shapiro R; Fung JJ; Zeevi A
Ther Drug Monit; 2001 Aug; 23(4):354-62. PubMed ID: 11477316
[TBL] [Abstract][Full Text] [Related]
35. An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates.
Vasquez EM; Petrenko Y; Jacobssen V; Sifontis NM; Testa G; Sankary H; Benedetti E
Transplant Proc; 2005; 37(1):175-7. PubMed ID: 15808585
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients.
Wei-lin W; Jing J; Shu-sen Z; Li-hua W; Ting-bo L; Song-feng Y; Sheng Y
Liver Transpl; 2006 May; 12(5):775-80. PubMed ID: 16628701
[TBL] [Abstract][Full Text] [Related]
37. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
[TBL] [Abstract][Full Text] [Related]
38. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P
Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314
[TBL] [Abstract][Full Text] [Related]
39. The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients.
Tavira B; Gómez J; Díaz-Corte C; Coronel D; Lopez-Larrea C; Suarez B; Coto E
J Hum Genet; 2015 May; 60(5):273-6. PubMed ID: 25673014
[TBL] [Abstract][Full Text] [Related]
40. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.
Anglicheau D; Verstuyft C; Laurent-Puig P; Becquemont L; Schlageter MH; Cassinat B; Beaune P; Legendre C; Thervet E
J Am Soc Nephrol; 2003 Jul; 14(7):1889-96. PubMed ID: 12819250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
